Sumitomo Pharma Co. Ltd (SMDPY PINK) stock market data APIs
$12.1783
0(0%)
as of November 11, 2026
Try our APIs with
free plan!
Sumitomo Pharma Co. Ltd Financial Data Overview
Price chart is built with
Anychart
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Prev. Close
12.1783
Open
12.1783
High
12.1783
Low
12.1783
52 wk Range
7.84-24.48
Market Cap
5 419 M
P/E Ratio
18.0299
Shares Outstanding
449 M
Revenue
492 662 M
EPS
0.2973
Beta
0.423
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sumitomo Pharma Co. Ltd data using free add-ons & libraries
Get Sumitomo Pharma Co. Ltd Fundamental Data
Sumitomo Pharma Co. Ltd Fundamental data includes:
- Net Revenue: 492 662 M
- EBITDA: 16 655 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-09-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sumitomo Pharma Co. Ltd News
New
Is Sumitomo Chemical Company (TSE:4005) Still Undervalued After A 41% Gain?
Sumitomo Chemical Company has delivered a 41.0% share price gain over the past three years, even as shorter term returns have been more mixed. That puts fresh focus on whether that move lines up with ...
Sumitomo Pharma America to Present New Clinical Data on Enzomenib and Nuvisertib at the 2026 American Society of Hematology Annual Meeting
– SMPA to present first data from ongoing Phase 2 clinical trial of enzomenib in patients with relapsed or refractory acute leukemia, with KMT2A rearrangements, an aggressive subtype of leukemia –...
Sumitomo Pharma (TSE:4506) Stock Climbs Despite Thin Q2 Earnings Margins
Sumitomo Pharma closed today at ¥1,884.5 after a sharp multi month climb, with the stock up about 51% over the past quarter. The Q2 2027 earnings release just landed and the headline is simple. Profi...
Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Breakthrough Therapy Designation for Treatment of R/R KMT2A-Rearranged Acute Leukemia
– Enzomenib is being evaluated as monotherapy in the registrational Phase 2 Horizen-1 study in relapsed/refractory (R/R) acute leukemia with KMT2A rearrangement or NPM1 mutation – Enzomenib is al...
Get Sumitomo Pharma Co. Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.